These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34302788)

  • 1. BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study.
    Cortese I; Beck ES; Al-Louzi O; Ohayon J; Andrada F; Osuorah I; Dwyer J; Billioux BJ; Dargah-Zada N; Schindler MK; Binder K; Reoma L; Norato G; Enose-Akahata Y; Smith BR; Monaco MC; Major EO; Jacobson S; Stroncek D; Highfill S; Panch S; Reich DS; Barrett J; Nath A; Muranski P
    Lancet Neurol; 2021 Aug; 20(8):639-652. PubMed ID: 34302788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.
    Muftuoglu M; Olson A; Marin D; Ahmed S; Mulanovich V; Tummala S; Chi TL; Ferrajoli A; Kaur I; Li L; Champlin R; Shpall EJ; Rezvani K
    N Engl J Med; 2018 Oct; 379(15):1443-1451. PubMed ID: 30304652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy.
    Nelson AS; Yalamarthi N; Yong MK; Blyth E
    Curr Opin Infect Dis; 2021 Dec; 34(6):627-634. PubMed ID: 34751182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.
    Chen Y; Trofe J; Gordon J; Autissier P; Woodle ES; Koralnik IJ
    J Clin Virol; 2008 Jun; 42(2):198-202. PubMed ID: 18295538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic BK Virus-Specific T-Cell Treatment in 2 Patients With Progressive Multifocal Leukoencephalopathy.
    Hopfner F; Möhn N; Eiz-Vesper B; Maecker-Kolhoff B; Gottlieb J; Blasczyk R; Mahmoudi N; Pars K; Adams O; Stangel M; Wattjes MP; Höglinger G; Skripuletz T
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34001660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy.
    Berzero G; Basso S; Stoppini L; Palermo A; Pichiecchio A; Paoletti M; Lucev F; Gerevini S; Rossi A; Vegezzi E; Diamanti L; Bini P; Gastaldi M; Delbue S; Perotti C; Seminari E; Faraci M; Luppi M; Baldanti F; Zecca M; Marchioni E; Comoli P
    Ann Neurol; 2021 Apr; 89(4):769-779. PubMed ID: 33459417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.
    Sospedra M; Schippling S; Yousef S; Jelcic I; Bofill-Mas S; Planas R; Stellmann JP; Demina V; Cinque P; Garcea R; Croughs T; Girones R; Martin R
    Clin Infect Dis; 2014 Dec; 59(11):1588-92. PubMed ID: 25214510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful BK virus-specific T cell therapy in a kidney transplant recipient with progressive multifocal leukoencephalopathy.
    Sempere A; Castillo N; Rudilla F; Querol S; Enrich E; Prat-Vidal C; Codinach M; Cofan F; Torregrossa V; Dieckmann F; Bodro M
    Am J Transplant; 2024 Sep; 24(9):1698-1702. PubMed ID: 38734417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient.
    Balduzzi A; Lucchini G; Hirsch HH; Basso S; Cioni M; Rovelli A; Zincone A; Grimaldi M; Corti P; Bonanomi S; Biondi A; Locatelli F; Biagi E; Comoli P
    Bone Marrow Transplant; 2011 Jul; 46(7):987-92. PubMed ID: 20921942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance.
    Mani J; Wang L; Hückelhoven AG; Schmitt A; Gedvilaite A; Jin N; Kleist C; Ho AD; Schmitt M
    Oncotarget; 2017 Jan; 8(2):2485-2500. PubMed ID: 27705933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients.
    Rubinstein JD; Jodele S; Heyenbruch D; Wilhelm J; Thomas S; Lutzko C; Zhu X; Leemhuis T; Cancelas JA; Keller M; Bollard CM; Hanley PJ; Boghdadly ZE; Mims A; Davies SM; Grimley MS; Nelson AS
    Transplant Cell Ther; 2022 Feb; 28(2):116.e1-116.e7. PubMed ID: 34785398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive Multifocal Leukoencephalopathy: Endemic Viruses and Lethal Brain Disease.
    Haley SA; Atwood WJ
    Annu Rev Virol; 2017 Sep; 4(1):349-367. PubMed ID: 28637388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML).
    Yang W; Beaudoin EL; Lu L; Du Pasquier RA; Kuroda MJ; Willemsen RA; Koralnik IJ; Junghans RP
    Int Immunol; 2007 Sep; 19(9):1083-93. PubMed ID: 17660502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.
    Lima MA; Marzocchetti A; Autissier P; Tompkins T; Chen Y; Gordon J; Clifford DB; Gandhi RT; Venna N; Berger JR; Koralnik IJ
    J Virol; 2007 Apr; 81(7):3361-8. PubMed ID: 17229701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies.
    Hadjadj J; Guffroy A; Delavaud C; Taieb G; Meyts I; Fresard A; Streichenberger N; L'Honneur AS; Rozenberg F; D'Aveni M; Aguilar C; Rosain J; Picard C; Mahlaoui N; Lecuit M; Hermine O; Lortholary O; Suarez F
    J Clin Immunol; 2019 Jan; 39(1):55-64. PubMed ID: 30552536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
    Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into progressive multifocal leukoencephalopathy.
    Koralnik IJ
    Curr Opin Neurol; 2004 Jun; 17(3):365-70. PubMed ID: 15167073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.
    Krymskaya L; Sharma MC; Martinez J; Haq W; Huang EC; Limaye AP; Diamond DJ; Lacey SF
    J Virol; 2005 Sep; 79(17):11170-8. PubMed ID: 16103168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
    Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
    Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of monoclonal antibodies to JC virus and their use in the diagnosis of progressive multifocal leucoencephalopathy.
    Knowles WA; Sharp IR; Efstratiou L; Hand JF; Gardner SD
    J Med Virol; 1991 Jun; 34(2):127-31. PubMed ID: 1653819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.